This is an automatically translated article.
Itopride invagen is usually indicated for the treatment of gastrointestinal symptoms caused by chronic gastritis. The use of Itopride invagen always has certain benefits and risks. Therefore, patients need to strictly follow the advice of taking the drug that the specialist advises to minimize the side effects.
1. What is Itopride invagen?
Itopride invagen belongs to the group of gastrointestinal drugs, used to treat chronic gastritis. Itopride invagen is prepared in the form of film-coated tablets and packed in a box of 2 blisters x 10 tablets. Each Itopride invagen tablet contains the main active ingredient, Itopride HCl, 50mg and other excipients, just enough for one tablet.
2. What is the effect of Itopride invagen?
2.1 Uses of the drug Itopride invagen The main active ingredient Itopride HCl in the drug works to increase the release of Acetylcholine (ACh) by antagonizing the D2 Dopamine receptor. At the same time, it prevents the breakdown of Acetylcholine through inhibition of Acetylcholinesterase, thereby increasing gastrointestinal motility. In addition, active ingredient Itopride HCl also has the ability to empty the stomach and reduce vomiting for patients with chronic gastritis.
2.2 Indications for the use of Itopride invagen Itopride invagen is usually prescribed by doctors to treat gastrointestinal symptoms related to chronic gastritis, including:
Treatment of a feeling of fullness belly . Treats and relieves upper abdominal pain. Repelling the phenomenon of anorexia. Treat other symptoms of chronic gastritis such as nausea, vomiting, or heartburn. 2.3 Contraindications to the use of Itopride invagen Do not use Itopride invagen for the following subjects:
Patients with a history of allergy or hypersensitivity to the active ingredient Itopride HCl or any other ingredients contained in the drug. Itopride invagen is contraindicated in pregnant or breastfeeding women unless absolutely necessary.
4. Dosage and how to use Itopride invagen
Dosage of Itopride invagen for adults as recommended by the doctor is 150mg of Itopride HCl, equivalent to 3 tablets of 50mg/day. Patients should divide the oral dose into 3 times / day, 1 tablet each time and take before meals. The dose of Itopride invagen can be adjusted down or down based on the age and medical condition of each patient.
Before treating symptoms of chronic gastritis with Itopride invagen, patients should carefully read the instruction leaflet or follow the instructions of a specialist. In addition, patients also need to take the drug in accordance with the recommended dose, avoid arbitrarily adjusting or stopping the drug without the doctor's approval.
In case of overdose of Itopride invagen and unexpected reactions occur, the patient should immediately notify the doctor or go to a medical facility for early treatment of symptoms. If the patient misses a dose of Itopride invagen, the patient should take it as soon as he remembers as soon as possible. However, if it is too close to the time for your next dose, it is best to skip the missed dose and take it as planned.
5. What are the side effects of Itopride invagen?
Itopride invagen can cause some side effects for patients during the treatment of chronic gastritis, including:
Headache, constipation, abdominal pain or diarrhea. Increased prolactin, leukopenia, increased ALT (GPT) or increased AST (GOT). Shock and hypersensitivity reactions, such as dyspnea, hypotension, urticaria, laryngeal edema, sweating, pale skin, etc. Notify your doctor for appropriate treatment. Symptoms of liver dysfunction, jaundice accompanied by elevated ALT (GPT), AST (GOT) or γ-GTP. When noticing any abnormal symptoms listed above, the patient should notify the doctor soon for a timely treatment and remedy. Delayed treatment of side effects, especially serious reactions, can be life-threatening and lead to dangerous complications.
6. Things to note during the use of Itopride invagen
6.1 What precautions should be taken while using Itopride invagen? Here are some things that patients need to keep in mind during the treatment of chronic gastritis with Itopride invagen:
The use of Itopride invagen may increase the activity of Acetylcholine. If gastrointestinal symptoms do not improve, patients should avoid prolonged use of Itopride invagen. Care should be taken when using Itopride invagen for the elderly because the physiological function of this subject has gradually declined, and it is easy to encounter adverse effects when taking the drug. If any of these reactions occur, the elderly patient should receive appropriate measures, such as discontinuing or reducing the dose of Itopride invagen. There are no specific data on the safety of Itopride invagen in children. Therefore, this gastrointestinal medicine should not be given to children without being evaluated and approved by a doctor. Itopride invagen should only be used by pregnant women or those planning to become pregnant when the benefits of the drug outweigh the risks to the patient. It is best to avoid using Itopride invagen for women who are breastfeeding. However, if necessary, the mother may consider avoiding breast-feeding during treatment with Itopride invagen or consult a physician. 6.2 Interactions of Itopride invagen with other drugs Care should be taken when using Itopride invagen in combination with the following drugs because they may have drug interactions:
Timepidium bromide. Tiquizium bromide. Scopolamine butyl bromide. The combination of Itopride invagen with the above anticholinergic drugs can reduce the effect of increasing gastrointestinal motility of the active ingredient Itopride HCl.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
